Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-23T08:15:23.322Z Has data issue: false hasContentIssue false
  • English
  • Français

Economic Activity and the Value of Medical Innovation during a Pandemic

Published online by Cambridge University Press:  09 June 2021

Casey B. Mulligan
Casey B. Mulligan*
Affiliation:
Department of Economics, University of Chicago, Chicago, IL, USA.
*
e-mail: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

The “shutdown” economy of April 2020 is compared to a normally functioning economy both in terms of market and nonmarket activities. Three novel methods and data indicate that a full shutdown of “nonessential” activities puts market production about 25 % below normal in the short run. At an annual rate, a full shutdown costs $9 trillion, or about $18,000 per household per quarter. Employment already fell 24 million by early April 2020. These costs indicate, among other things, the value of innovation in both health and general business sectors that can accelerate the time when, and the degree to which, normal activity resumes.

Keywords

medical innovationvaccinationpandemicnational accountingE01I18O31
Type
Article
Information
Journal of Benefit-Cost Analysis , Volume 12 , Issue 3 , Fall 2021 , pp. 420 - 440
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the Society for Benefit-Cost Analysis

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexander, Diane, and Karger, Ezra. 2020. “Do Stay-at-Home Orders Cause People to Stay at Home? Effects of Stay-at-Home Orders on Consumer Behavior.” Federal Reserve Bank of Chicago Working Paper Series.CrossRefGoogle Scholar
Atkinson, Anthony B., and Stern, Nicholas H.. 1974. “Pigou, Taxation and Public Goods.” The Review of Economic Studies, 41: 119–128.CrossRefGoogle Scholar
Barro, Robert J., Ursúa, José F., and Weng, Joanna. 2020. “The Coronavirus and the Great Influenza Pandemic: Lessons from the “Spanish Flu” for the Coronavirus’s Potential Effects on Mortality and Economic Activity.” NBER Working Paper, no. 26866.CrossRefGoogle Scholar
Becker, Gary S. 1964/1993. Human Capital: A Theoretical and Empirical Analysis, with Special Reference to Education. Chicago, IL: University of Chicago Press.Google Scholar
Bick, Alexander, and Blandin, Adam. 2020. “Real Time Labor Market Estimates During the 2020 Coronavirus Outbreak.” alexbick.weebly.com. April 15, 2020. https://alexbick.weebly.com/uploads/1/0/1/3/101306056/bb_covid.pdf.CrossRefGoogle Scholar
Bick, Alexander, and Blandin, Adam. 2021. “Real Time Labor Market Estimates During the 2020 Coronavirus Outbreak.” alexbick.weebly.com. February 19, 2021. https://drive.google.com/file/d/1uQrlBJ_w4b2Fps6Zp9qgc-9pMnbC-mjq/view.Google Scholar
Boburg, Shawn, O’Harrow, Robert Jr., Satija, Neena, and Goldstein, Amy. 2020. “Inside the Coronavirus Testing Failure: Alarm and Dismay Among the Scientists Who Sought to Help.” The Washington Post, April 3, 2020.Google Scholar
Boserup, Brad, McKenney, Mark, and Elkbuli, Adel. 2020. “Alarming Trends in US Domestic Violence during the COVID-19 Pandemic.” The American Journal of Emergency Medicine, 38: 2753–2755.CrossRefGoogle ScholarPubMed
Breton, Theodore R. 2013. “Were Mankiw, Romer, and Weil right? A Reconciliation of the Micro and Macro Effects of Schooling on Income.” Macroeconomic Dynamics, 17: 1023–1054.CrossRefGoogle Scholar
Congressional Budget Office. 2020a. “Preliminary Estimate of the Effects of H.R. 6201, the Families First Coronavirus Response Act.” Congressional Budget Office. April 2, 2020. https://www.cbo.gov/publication/56316.Google Scholar
Congressional Budget Office. 2020b. “Preliminary Estimate of the Effects of H.R. 748, the CARES Act, Public Law 116-136.” Congressional Budget Office. April 16, 2020. https://www.cbo.gov/publication/56334.Google Scholar
Congressional Budget Office. 2021a. “Summary Estimate for Divisions M Through FF, H.R.133.” cbo.gov. January 14, 2021. https://www.cbo.gov/system/files/2021-01/PL_116-260_Summary.pdf.Google Scholar
Congressional Budget Office. 2021b. “Estimated Budgetary Effects of H.R. 1319, American Rescue Plan Act of 2021 as Passed by the Senate.” cbo.gov. March 10, 2021. https://www.cbo.gov/system/files/2021-03/Estimated_Budgetary_Effects_of_HR_1319_as_passed_0.pdf.Google Scholar
Council of Economic Advisers. 2019a. Economic Report of the President. Executive Office of the President.Google Scholar
Council of Economic Advisers. 2019b. Mitigating the Impact of Pandemic Influenza through Vaccine Innovation. Executive Office of the President.Google Scholar
Dahlby, Bev. 2008. The Marginal Cost of Public Funds: Theory and Applications. Cambridge, MA: MIT Press.CrossRefGoogle Scholar
DiMasi, Joseph A., Grabowski, Henry G., and Hansen, Ronald W.. 2016. “Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs.” Journal of Health Economics, 47: 20–33.CrossRefGoogle ScholarPubMed
Eichenbaum, Martin S., Rebelo, Sergio, and Trabandt, Mathias. 2020. “The Macroeconomics of Epidemics.” googlegroups.com. March 23, 2020. https://www.nber.org/papers/w26882.Google Scholar
European Central Bank. 2004. “The Impact of the Number of Working Days on Euro Area GDP in 2004.” Monthly Bulletin, June 2004: 51–63.Google Scholar
Falk, Amy, Benda, Alison, Falk, Peter, Steffen, Sarah, Wallace, Zachary, and Høeg, Tracy Beth. 2021. “COVID-19 Cases and Transmission in 17 K–12 Schools—Wood County, Wisconsin, August 31–November 29, 2020.” Morbidity and Mortality Weekly Report, 70: 136.CrossRefGoogle ScholarPubMed
Fleming, Matthew H., Roman, John, and Farrell, Graham. 2000. “The Shadow Economy.” Journal of International Affairs, 53: 387–409.Google Scholar
Food and Drug Administration. 1998 “‘Off-Label’ and Investigational Use Of Marketed Drugs, Biologics, and Medical Devices.” fda.gov. January 1998. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/label-and-investigational-use-marketed-drugs-biologics-and-medical-devices.Google Scholar
Food and Drug Administration. 2017. “22 Case Studies Where Phase 2 and Phase 3 Trials Had Divergent Results.” fda.gov. https://www.fda.gov/media/102332/download.Google Scholar
Friedson, Andrew I., McNichols, Drew, Sabia, Joseph J., and Dave, Dhaval. 2021. “Shelter-in-Place Orders and Public Health: Evidence from California During the COVID-19 Pandemic.” Journal of Policy Analysis and Management, 40: 258–283.CrossRefGoogle Scholar
Goolsbee, Austan, and Syverson, Chad. 2021. “Fear, Lockdown, and Diversion: Comparing Drivers of Pandemic Economic Decline 2020.” Journal of Public Economics, 193: 104311.CrossRefGoogle ScholarPubMed
Grady, Denise, Goodnough, Abby, and Weiland, Noah. 2020. “F.D.A. Authorizes Moderna Vaccine, Adding Millions of Doses to U.S. Supply.” New York Times, December 19, 2020: A1.Google Scholar
Grijalva, Carlos G., et al. 2020. “Transmission of SARS-COV-2 Infections in Households—Tennessee and Wisconsin, April–September 2020.” Morbidity and Mortality Weekly Report, 69: 1631.Google Scholar
Gupta, Sumedha, et al. 2020. “Tracking Public and Private Responses to the COVID-19 Epidemic: Evidence from State and Local Government Actions.” Technical Report, National Bureau of Economic Research.CrossRefGoogle Scholar
Hartwick, John M. 1990. “Natural Resources, National Accounting and Economic Depreciation.” Journal of Public Economics, 43: 291–304.CrossRefGoogle Scholar
Jaffe, Sonia, Minton, Robert, Mulligan, Casey B., and Murphy, Kevin M.. 2019. Chicago Price Theory. Princeton, NJ: Princeton University Press (ChicagoPriceTheory.com).Google Scholar
Jorgenson, Dale W. 2009. “A New Architecture for the US National Accounts.” Review of Income and Wealth, 55: 1–42.CrossRefGoogle Scholar
Jorgenson, Dale W. 2010. “Human Capital and the National Accounts.” Survey of Current Business, 90: 54–56.Google Scholar
Jørring, Adam, Lo, Andrew W., Philipson, Tomas J., Singh, Manita, and Thakor, Richard T.. 2017. “Sharing R&D Risk in Healthcare via FDA Hedges.” NBER Working Paper, no. 23344.Google Scholar
Kalil, Andre C. 2020. “Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.” JAMA, 3: 1897–1898.CrossRefGoogle Scholar
Katz, Eric. 2019. “Agencies Paid Federal Employees $3.7 Billion Not to Work During Recent Shutdowns.” govexec.com. September 17, 2019. https://www.govexec.com/pay-benefits/2019/09/agencies-paid-federal-employees-37-billion-not-work-during-recent-shutdowns/159936/.Google Scholar
Klein, Daniel B., and Tabarrok, Alexander. 2002. “Is the FDA Safe and Effective.” An extensive website sponsored by the Independent Institute (FDAreview.org). Link.Google Scholar
Kuhfeld, Megan, Tarasawa, Beth, Johnson, Angela, Ruzek, Erik, and Lewis, Karyn. 2020. Learning During COVID-19: Initial Findings on Students’ Reading and Math Achievement and Growth. Portland, OR: NWEA Research.Google Scholar
Lichtenberg, Frank R. 2003. “Pharmaceutical Innovation, Mortality Reduction, and Economic Growth.” In Murphy, Kevin M. and Topel, Robert H. (Eds.) Measuring the Gains From Medical Research: An Economic Approach 74–109. Chicago: University of Chicago Press.CrossRefGoogle Scholar
Mervosh, Sarah, Lu, Denise, and Swales, Vanessa. 2020. “See Which States and Cities Have Told Residents to Stay at Home.” New York Times, April 20, 2020.Google Scholar
Mincer, Jacob. 1974. “Schooling, Experience, and Earnings. Human Behavior & Social Institutions No. 2.” (ERIC).Google Scholar
Mulligan, Casey B. 1998. “Substitution Over Time: Another Look at Life-Cycle Labor Supply.” NBER Macroeconomics Annual, 13: 75–134.CrossRefGoogle Scholar
Mulligan, Casey B. 2012. The Redistribution Recession. New York: Oxford University Press (redistributionrecession.com).CrossRefGoogle Scholar
Mulligan, Casey B. 2014. “Uncertainty, Redistribution, and the Labor Market since 2007.” IZA Journal of Labor Policy, 3(8): 1–16.CrossRefGoogle Scholar
Mulligan, Casey B. 2020. “Deaths of Despair and the Incidence of Excess Mortality in 2020.” NBER Working Paper, no. 28303.Google Scholar
Mulligan, Casey B. 2021a. “How Chicago Economics Helped End a Pandemic.” ChicagoPriceTheory.com. February 2021. http://warpspeed.chicagopricetheory.com.Google Scholar
Mulligan, Casey B. 2021b. “The Backward Art of Slowing the Spread? Congregation Efficiencies during COVID-19.” NBER Working Paper, no. 28737.Google Scholar
Mulligan, Casey B., and Blase, Brian. 2020. “Congress Can Still Save the Recovery.” Wall Street Journal, April 8, 2020.Google Scholar
Mulligan, Casey B., Murphy, Kevin M., and Topel, Robert H.. 2020. “Some Basic Economics of COVID-19 Policy.” Manuscript, University of Chicago.Google Scholar
Murphy, Kevin M., and Topel, Robert H.. 2003. “The Economic Value of Medical Research.” In Murphy, Kevin M. and Topel, Robert H. (Eds.) Measuring the Gains From Medical Research: An Economic Approach 74–109. Chicago: University of Chicago Press.CrossRefGoogle Scholar
NBC News. 2020. “Dr. Fauci Explains Possible Timeline for Coronavirus Vaccine.” nbcnews.com. March 3, 2020. https://www.nbcnews.com/video/dr-anthony-fauci-explains-possible-timeline-for-coronavirus-vaccine-talks-remdesivir-medication-79901253901.Google Scholar
Nordhaus, William D., and Kokkelenberg, Edward C.. 1999. Nature’s Numbers. Washington, DC: National Academy Press.Google Scholar
Peltzman, Sam. 1973. “An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments.” Journal of Political Economy, 81: 1049–1091.CrossRefGoogle Scholar
Philipson, Tomas J., and Sun, Eric. 2008. “Is the Food and Drug Administration Safe and Effective?” Journal of Economic Perspectives, 22: 85–102.CrossRefGoogle ScholarPubMed
Philipson, Tomas, and Posner, Richard A.. 1993. Private Choices and Public Health: An Economic Interpretation of the AIDS Epidemic. Cambridge, MA: Harvard University.Google Scholar
PhRMA. 2020. “The Biopharmaceutical Industry is Leading the Way in Developing New Vaccines and Treatments for COVID-19.” phrma.org. March 13, 2020. https://phrma.org/-/media/Project/PhRMA/PhRMA-Org/PhRMA-Org/PDF/G-I/IndustryResponseCOVID19.pdf.Google Scholar
Renaissance Learning. 2020. How Kids Are Performing: Tracking the Impact of COVID-19 on Reading and Mathematics Achievement. Wisconsin Rapids, WI: Renaissance Learning, Inc.Google Scholar
Richterman, Aaron, Meyerowitz, Eric A., and Cevik, Muge. 2020. “Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health.” JAMA, 324: 2155–2156.CrossRefGoogle ScholarPubMed
Rosen, Sherwin. 1972. “Learning and Experience in the Labor Market.” Journal of Human Resources, 7: 326–342.CrossRefGoogle Scholar
U.S. President. 2019. “Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health, Executive Order 13887 of September 19, 2019.” Federal Register, September 24, 2019: 49935.Google Scholar
World Health Organization. 2017. “Contact Tracing.” who.int. May 2017. https://www.who.int/features/qa/contact-tracing/en/.Google Scholar
Zimmerman, Kanecia O., et al. 2021. “Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools.” Pediatrics, 147: 1–8.CrossRefGoogle ScholarPubMed